相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Store at -20℃,2 years
- 保质期:
Store at -20℃,2 years
- 英文名:
LP-211
- 库存:
现询
- 供应商:
北京索莱宝科技有限公司
- CAS号:
1052147-86-0
- 规格:
50mg/25mg/10mg/5mg/1mg
| 规格: | 50mg | 产品价格: | ¥3890.0 |
|---|---|---|---|
| 规格: | 25mg | 产品价格: | ¥2428.0 |
| 规格: | 10mg | 产品价格: | ¥1235.0 |
| 规格: | 5mg | 产品价格: | ¥790.0 |
| 规格: | 1mg | 产品价格: | ¥344.0 |
| 基本信息 | |
| CAS | No.1052147-86-0 |
| 英文名称 | LP-211 |
| 别名 | N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide |
| 分子式 | C30H34N4O |
| 分子量 | 466.62 |
| 溶解性 | Soluble in DMSO |
| 纯度 | ≥98% |
| 外观(性状) | Light yellow to yellow Oil |
| 储存条件 | Store at -20℃,2 years |
| SMILES | C1CN(CCN1CCCCCC(=O)NCC2=CC=C(C=C2)C#N)C3=CC=CC=C3C4=CC=CC=C4 |
| 靶点 | 5-HT Receptor |
| 通路 | Neuronal Signaling;GPCR & G Protein |
| 背景说明 | LP-211是一种选择性的 5-HT7 受体激动剂。 |
| 生物活性 | LP-211 is a selective and blood?brain barrier penetrant 5-HT7 receptor agonist, with a Ki of 0.58 nM, with high selectivity over 5-HT1A receptor (Ki, 188 nM) and D2 receptor (Ki, 142 nM).[1-3] |
| In Vitro | LP-211 is a selective 5-HT7 receptor agonist, with a Ki of 0.58 nM, 324- and 245-fold selectivity over 5-HT1A receptor (Ki, 188 nM) and D2 receptor (Ki, 142 nM). LP-211 shows agonist properties with an EC50 of 0.6 μM[1]. |
| 细胞实验 | LP-211 (10 mg/kg, i.p.) rapidly reaches the systemic circulation in the mouse, with mean Cmax of 0.76 ± 0.32 μg/mL at 30 min[1]. LP-211 (0.003-0.3 mg/kg, i.p.) significantly increases the micturition volume in a dose-dependent manner, and causes significant increases in voiding efficiency in spinal cord-injured (SCI) rats, and such effects can be completely reversed by SB-269970[2]. LP-211 (0.25 and 0.50 mg/kg i.p.) improves consolidation of chamber-shape memory in rats, resulting in significant novelty-induced hyperactivity and recognition[3]. |
| 动物实验 | Thirty male adult Wistar rats (300-450 g) are assessed for novelty preference behavior after acute treatment (administered immediately after the training session and 24 h before the test session). After a 4 weeks wash out, the rPDT is conducted to evaluate attraction from a greater/uncertain reward, with a sub-chronic treatment (five injections, immediately after sessions which follow the indifferent point). Food restriction, imposed by the experimenter through a limited quantity of food given at the end of each rPDT session, is applied to increase motivation to work for food delivery. All behavioral tests take place between 9:30 am and 4:00 pm. Rats are randomly assigned to treatment (LP-211 at 0.25 or 0.50 mg/kg i.p.) and control groups (injection volume 10 mL/kg; n?=?10 per group). The brain penetrant 5-HT7R agonist LP-211 is dissolved in a vehicle solution of 1% dimethyl sulfoxide (DMSO) in saline (0.9% NaCl). Control group receives the vehicle strictly in the same conditions[3]. |
| 激酶实验 | Binding of [3H]-LSD at rat cloned 5-HT7 receptor is performed in the assay. In 1 mL of incubation buffer (50 mM Tris, 10 mM MgCl2 and 0.5 mM EDTA, pH 7.4) are suspended 30 μg of membranes, 2.5 nM [3H]-LSD, LP-211 (6?9 concentrations). The samples are incubated for 60 min at 37°C. The incubation is stopped by rapid filtration on GF/A glass fiber filters (presoaked in 0.5% polyethylenimine for 30 min). The filters are washed with 3 × 53 mL of ice-cold buffer (50 mM Tris, pH 7.4). Nonspecific binding is determined in the presence of 10 μM 5-CT. Approximately 90% of specific binding is determined under these conditions[1]. |
| 数据来源文献 | [1]. Leopoldo M, et al. Structural modifications of N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides: influence on lipophilicity and 5-HT7 receptor activity. Part III. J Med Chem. 2008 Sep 25;51(18):5813-22. [2]. Norouzi-Javidan A, et al. Effect of 5-HT7 receptor agonist, LP-211, on micturition following spinal cord injury in male rats. Am J Transl Res. 2016 Jun 15;8(6):2525-33. eCollection 2016. [3]. Beaudet G, et al. LP-211, a selective 5-HT7 receptor agonist, increases novelty-preference and promotes risk-prone behavior in rats. Synapse. 2017 Dec;71(12). |
| 单位 | 瓶 |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验介素(Interleukin,IL)-1β、IL-2 和 IL-8 升高。 癫痫发作期相关的炎症因子 1.IL-6 在中枢神经系统中发挥着极为重要的作用,不但影响神经元的分化、发育,还与神经系统兴奋性的产生和维持有着极为密切的关系。目前多数观点认为其具有抗癫痫脑损伤、保护神经和营养神经作用,有利于神经元修复。有研究表明 IL-6的缺乏增加了癫痫发作的可能,提示 IL-6 具有在脑损伤过程中起到神经保护因子的功能。 在癫痫发作后的 IL-6 水平在发作后 3~24h 各时间点均较基线明显升高,差异有显著性(P
相关专题 &NBS p; Interleukin 18 (interferon-gamma-inducing factor) IL-18 is a cytokine that belongs to the IL-1 superfamily and is produced by macrophages and other Cell s. IL-18 works by binding
脂肪燃烧的指令从哪里来?Nature 揭示神经免疫互作如何与
的交感神经纤维网络。为了进一步检测肾上腺素是否能够调控局部 ILC2s,他们使用 6-羟基多巴胺(6-OHDA)诱导儿茶酚胺能神经元损伤,结果发现 ILC2s 来源的 IL-5、IL-13 随之显著减少。随后,借助小鼠模型,选择性消融外周交感神经元亦可导致 ILC2 活性受损。相比之下,激活 β2 肾上腺素能受体(ADRB2)则会导致内脏脂肪中 ILC2 来源的细胞因子上调,激活神经元也可使得 ILC2 功能增强。图片来源:Nature接下来,为了研究交感神经调节脂肪 ILC2s 的机制,他们将小鼠
技术资料暂无技术资料 索取技术资料









